(Q43762659)

26 November 2017

Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia (English)

1 reference

26 November 2017

0 references

0 references

1 reference

A Laakso

1

1 reference

26 November 2017

J Bergman

2

1 reference

26 November 2017

M Haaparanta

3

1 reference

26 November 2017

H Vilkman

4

1 reference

26 November 2017

O Solin

5

1 reference

26 November 2017

E Syvälahti

6

1 reference

26 November 2017

J Hietala

7

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

26 November 2017

6

1 reference

inferred from page(s)

published in

Schizophrenia Research

1 reference

26 November 2017

52

1 reference

26 November 2017

1-2

1 reference

26 November 2017

115-120

1 reference

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900095-5

7 January 2021

Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900095-5

7 January 2021

Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900095-5

7 January 2021

Mesostriatal and mesolimbic dopamine uptake binding sites are reduced in Parkinson's disease and progressive supranuclear palsy: a quantitative autoradiographic study using [3H]mazindol.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900095-5

7 January 2021

[3H] GBR 12935 binding to the dopamine uptake site in post-mortem brain tissue in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900095-5

7 January 2021

Structural brain changes in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900095-5

7 January 2021

A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900095-5

7 January 2021

Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900095-5

7 January 2021

Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900095-5

7 January 2021

Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900095-5

7 January 2021

[3H]GBR-12935 binding sites in human striatal membranes: binding characteristics and changes in parkinsonians and schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900095-5

7 January 2021

Quantitative autoradiography of dopamine-D1 receptors, D2 receptors, and dopamine uptake sites in postmortem striatal specimens from schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900095-5

7 January 2021

[18F]CFT [(18F)WIN 35,428], a radioligand to study the dopamine transporter with PET: characterization in human subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900095-5

7 January 2021

Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900095-5

7 January 2021

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900095-5

7 January 2021

Dopamine and serotonin transporters in patients with schizophrenia: an imaging study with [(123)I]beta-CIT.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900095-5

7 January 2021

Dopaminergic mechanisms in idiopathic and drug-induced psychoses

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900095-5

7 January 2021

Five-factor model of schizophrenia. Initial validation

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900095-5

7 January 2021

Five factor model of schizophrenia: replication across samples

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900095-5

7 January 2021

Dopamine uptake sites and dopamine receptors in Parkinson's disease and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900095-5

7 January 2021

Neuroleptics and dopamine transporters.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900095-5

7 January 2021

Elevated dopa decarboxylase activity in living brain of patients with psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900095-5

7 January 2021

Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900095-5

7 January 2021

Brain dopamine transporter: gender differences and effect of chronic haloperidol.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900095-5

7 January 2021

Dorsal striatal size, shape, and metabolic rate in never-medicated and previously medicated schizophrenics performing a verbal learning task

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900095-5

7 January 2021

Comparison of [3H]WIN 35,428 binding, a marker for dopamine transporter, in embryonic mesencephalic neuronal cultures with striatal membranes of adult rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900095-5

7 January 2021

Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900095-5

7 January 2021

10.1016/S0920-9964(00)00095-5

Identifiers

DOI

1 reference

26 November 2017

1 reference